Federal contract award
75F40124F19005
ORDER AGAINST 75F40121D00009 QIAGEN IDIQ FOR PURCHASE OF MOLECULAR BIOLOGY REAGENTS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | 75F40121D00009 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $92.3K |
| Current contract value | $92.3K |
| Potential contract value / ceiling | $92.3K |
| Start date | Aug 2, 2024 |
| Current end date | Jun 14, 2025 |
| Potential end date | Jun 14, 2025 |
| Latest award activity | Jul 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 23, 2026 | P00001 | $-888 | ORDER AGAINST 75F40121D00009 QIAGEN IDIQ FOR PURCHASE OF MOLECULAR BIOLOGY REAGENTS. |
| Aug 2, 2024 | 0 | $93.1K | ORDER AGAINST 75F40121D00009 QIAGEN IDIQ FOR PURCHASE OF MOLECULAR BIOLOGY REAGENTS. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.